Yazar "Altintas, A." seçeneğine göre listele
Listeleniyor 1 - 15 / 15
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe The corelation between serum VEGF levels and known prognostic risk factors in colorectal carcinoma(Amer Soc Clinical Oncology, 2008) Bestas, R.; Isikdogan, A.; Cil, T.; Batun, S.; Altintas, A.[Abstract Not Available]Öğe Efficacy of recombinant FVIIA treatment in inhibitor positive hemophilic patients and in Glanzmann thrombasthenia: Single center experience(Ferrata Storti Foundation, 2007) Altintas, A.; Pasa, S.; Urakci, Z.; Muftuoglu, O. E.; Cil, T.[Abstract Not Available]Öğe THE EFFICACY OF RITUXIMAB IN PATIENTS WITH SPLENECTOMIZED REFRACTORY CHRONIC IDIOPATHIC THROMBOCYTHOPENIC PURPURA(Ferrata Storti Foundation, 2008) Pasa, S.; Altintas, A.; Cil, T.; Danis, R.; Ayyildiz, O.[Abstract Not Available]Öğe Evaluation of endothelial function in patient with Sheehans syndrome and the effect of hormone replacement treatment except growth hormone on endothelial dysfunction(Ferrata Storti Foundation, 2007) Pasa, S.; Altintas, A.; Can, A.; Sayar, S.[Abstract Not Available]Öğe Factor V leiden and G20210A prothrombin mutations in patient with recurrent pregnancy loss: Data from southeast of Turkey(Ferrata Storti Foundation, 2007) Altintas, A.; Pasa, S.; Ayyildiz, O.; Cil, T.[Abstract Not Available]Öğe Hepatitis B and C viruses seroprevalence of cancer patients in southeastern region of Turkey(Pergamon-Elsevier Science Ltd, 2007) Cil, T.; Altintas, A.; Pasa, S.; Kaplan, M.; Isikdogan, A.[Abstract Not Available]Öğe Hereditary hemochromatosis gene mutations in the south eastern region of Turkey(Ferrata Storti Foundation, 2007) Altintas, A.; Pasa, S.; Cil, T.; Devecioglu, B.; Ayyildiz, O.[Abstract Not Available]Öğe Inhibitors in hemophilia A and B in Souteast of Turkey(Ferrata Storti Foundation, 2007) Pasa, S.; Altintas, A.; Cil, T.; Atayan, Y.; Ayyildiz, O.[Abstract Not Available]Öğe NT-Probnp levels to perspectively assess acut cardiac failure after adjuvant doxorubicine therapy in early breast cancer patients(Amer Soc Clinical Oncology, 2008) Cil, T.; Altintas, A.; Pasa, S.; Kaplan, M. A.; Alan, S.; Isikdogan, A.[Abstract Not Available]Öğe Prevalence and clinical significance of elevated antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpura(Ferrata Storti Foundation, 2007) Altintas, A.; Pasa, S.; Ozel, A.; Okur, N.; Okur, N.[Abstract Not Available]Öğe PREVALENCE OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES POSITIVITY IN PATIENTS WITH HODGKIN AND NON-HODGKIN LYMPHOMA(Oxford Univ Press, 2008) Cil, T.; Altintas, A.; Pasa, S.; Isikdogan, A.[Abstract Not Available]Öğe Pulmonary hypertension in essential thrombocythemia(Ferrata Storti Foundation, 2007) Altintas, A.; Boyraz, T.; Pasa, S.; Cil, T.; Kaplan, M. A.; Ayyildiz, O.[Abstract Not Available]Öğe Reduced folat carrier gene status in colorectal, gastric, and pancreatic cancer(Amer Soc Clinical Oncology, 2009) Cil, T.; Tuzun, A. Y.; Altintas, A.; Batum, S.; Isikdogan, A.; Yurt, M.[Abstract Not Available]Öğe The relation between chronic idiopathic thrombocytopenic purpura and thyroid autoantibodies(Ferrata Storti Foundation, 2007) Altintas, A.; Pasa, S.; Parmaksiz, E.[Abstract Not Available]Öğe Successful total hip replacement in a patient with severe haemophilia A with inhibitors using recombinant factor VIIa(Blackwell Publishing, 2008) Pasa, S.; Altintas, A.; Cil, T.; Danis, R.; Subasi, M.; Ayyildiz, O.; Muftuoglu, E.[Abstract Not Available]
